JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Ashwani Kumar Puri as Non- Executive Independent Director of the company w.e.f. May 14, 2025.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has appointed Mr. Ashwani Kumar Puri as an additional Non-Executive Independent Director with effect from May 14, 2025. He will hold office until the next Annual General Meeting of the company. Mr. Puri is a Chartered Accountant and Certified Management Accountant who spent over 33 years at PwC, including 22 years as a partner, and served as India Advisory Services Leader. He currently serves as an independent director on the boards of Titan Company, Travel Food Services, and Healthium Medtech. He is not related to any existing director on the JB Chemicals board and is not debarred from holding directorship by any regulator.
This is a routine board-level appointment of an experienced independent director with strong governance and advisory background. It is unlikely to have any immediate material impact on the stock price, though it may strengthen the company's governance framework.